Concepedia

Kathleen Haverty

KH

3

Publications

91

Citations

3

H-Index

2009

Active since

Affiliations

Boehringer Ingelheim (United States)(Current)

Kathleen Haverty is an author at Boehringer Ingelheim (United States) specializing in drug development, drug discovery, and pharmacotherapy.

Top concepts

Publications per year

2009–2012

3

Publications

3

Improving potency and selectivity of a new class of non-Zn-chelating MMP-13 inhibitors

Alexander Heim‐Riether, Steven J. Taylor, Shuang Liang et al. · Bioorganic & Medicinal Chemistry Letters · 2009 · 50 citations · Full text

, , +8

SAR studies of non-zinc-chelating MMP-13 inhibitors: Improving selectivity and metabolic stability

Donghong A. Gao, Zhaoming Xiong, Alexander Heim‐Riether et al. · Bioorganic & Medicinal Chemistry Letters · 2010 · 30 citations · Full text

, , +10

Exploration of cathepsin S inhibitors characterized by a triazole P1–P2 amide replacement

Neil Moss, Zhaoming Xiong, Mike Burke et al. · Bioorganic & Medicinal Chemistry Letters · 2012 · 11 citations · Full text

, , +9

Rows per page

1–3 of 3